MediPoint: Sports Medicine - EU Analysis and Market Forecasts

NEW YORK, April 28, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

MediPoint: Sports Medicine - EU Analysis and Market Forecasts

http://www.reportlinker.com/p02088223/MediPoint-Sports-Medicine---EU-Analysis-and-Market-Forecasts.html

MediPoint: Sports Medicine - EU Analysis and Market Forecasts

Summary

This report focuses on the sports medicine market, which includes implants and arthroscopic capital equipment. The orthopedic sports medicine market has been estimated in this report and covers the US, France, Germany, Italy, Spain, the UK, Japan, Brazil, China and India. The report provides unmet needs, future adoption and compound annual growth rates (CAGR). GlobalData's analysis shows that while the orthopedics implant market is mature, sports medicine is an area with the potential for significant international growth. With the market, the US remains to be the largest market with the EU to follow and growing. The APAC region while markedly smaller has a large potential patient population.The top six to seven market leaders continue to dominate the market through technological innovation and investment in establishing strong distribution networks. The major opportunity lies within technological advancement and the clinical trials to prove effectiveness of new techniques.

The EU market is still the second largest market in sports medicine. The overwhelming market leaders across all the EU countries are Smith & Nephew and Arthrex. Germany remains the leader, with the greatest market size, as the country is often a pioneer in orthopedics and has a strong local manufacturing base. The market in Germany is held by the major players profiled in this report. Additionally, B. Braun Melsungen is a company that holds significant market share France, Germany, and Italy.

Scope

- An overview of Sports Medicine, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.
- Annualized SA sports medicine market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020.
- Investigation of current and future market competition for sports medicine.
- Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.
- Competitor assessment including device approval analysis and device sales forecasts.
- Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.
- Analysis of unmet needs within the market and opportunities for future players.
- Technology trends evaluation to assess strength of pipeline.
- An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines.
- Company profiles including business description, financial overview and SWOT analysis.
- Coverage of key market players.
- Strategic assessment of the sports medicine sector through market impact analysis, future market scenario and company analysis.
- Direct quotes from Key Opinion Leaders (KOL) as well as doctors

Reasons to buy

- Understand the trends shaping and driving the EU sports medicine market.
- Realize device preferences of physicians who have performed the tests already.
- Access market sizing, forecasts and quantified growth opportunities in EU sports medicine market through 2018.
- Quantify candidate patient populations to better design product pricing & launch plans.
- Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape.
- Perform benchmarking analysis of growth opportunities against currently marketed products.
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth.
- What's the next big thing in EU sports medicine market landscape? Identify, understand and capitalize.

1 Table of Contents

2 Introduction 22
2.1 Catalyst 23
2.2 Related Reports 25
2.3 Upcoming Related Reports 25
3 Clinical Outcomes 26
3.1 Conservative Treatments 26
3.1.1 Immobilization and Bracing 27
3.1.2 Physical Therapy 27
3.1.3 Muscle Stimulation 28
3.2 Drug Therapy 29
3.2.1 Nutritional Supplements 29
3.2.2 Analgesics and NSAIDs 29
3.2.3 Corticosteroids 29
3.2.4 Viscosupplementation 30
3.3 Soft Tissue Repair 30
3.4 Arthroscopy 32

3.5 Plates and Screws 33
3.6 Joint Replacement 34
4 Industry Overview 35
4.1 Overview 35
4.2 Procedure Trends 36
4.2.1 EU 36
4.3 Market Access 38
4.3.1 EU 38
4.4 Disputes and Settlements 46
4.4.1 Smith & Nephew Granted an Injunction Against Arthrex 46
4.4.2 KFx Medical and Smith & Nephew Enter Into Licensing Agreement 46
4.4.3 KFx Medical Wins Patent Infringement Lawsuit Against Arthrex 46
4.4.4 ArthroCare and Smith & Nephew Settle Legal Disputes 46
4.5 Mergers, Acquisitions, Partnerships, and Other Deals 47
4.5.1 Stryker Acquires Pivot Medical 47
4.5.2 Smith & Nephew Announces Acquisition of ArthroCare 47

4.5.3 Smith & Nephew Acquires Plato Grup Assets 47
4.5.4 Smith & Nephew Announces Acquisition of Its Brazil Distribution Business 47
4.5.5 Kensey Nash Acquires Minority Stake in Orteq Sports Medicine 48
4.5.6 Tornier Acquires C2M Medical 48
4.5.7 Tornier Signs Licensing Agreement with T.A.G. Medical Products Corporation 48
4.5.8 Biomet Acquires Cartilix 48
4.5.9 Biomet Sports Medicine Enters Into Deal With Marc Tec 49
4.6 Economic Impact 49
4.6.1 Developed Countries 49
4.6.2 Emerging Markets 51
5 Unmet Needs 53
5.1 Long-Term Clinical Data 53
5.1.1 Hip Arthroscopic Implants Clinical Data 53
5.1.2 Rotator Cuff Injury Clinical Data 53
5.2 Cartilage and Meniscal Repair Product Development 54
5.2.1 Knee Meniscus Treatment 54
5.2.2 Hip Cartilage Product Development 56
5.3 Biologics for Faster Healing 57
5.4 Standardization and Improvement of Instruments 58
5.4.1 Hip and Shoulder Instrumentation 58
5.4.2 Screwdriver Standardization 59

5.5 Fellowship Training Programs 59
5.6 Advanced Materials Research 60
5.7 Bioabsorbable Technology Development 62
5.8 Centralization 63
5.9 Need for Cost-Containment 64
5.10 Suture Anchor Product Development 65
6 Market Opportunity Analysis 67
6.1 Adding More Training Programs 67
6.2 Product Line Extensions 67
6.3 Lack of Pricing Pressure in Sports Medicine 68
6.4 Mergers and Acquisitions 69
6.5 Seasonality of Sports Medicine 70
6.6 Emerging Markets 70
6.7 Minimally-Invasive Surgical Preference 71
7 Market Drivers, Barriers and Substitutes 72
7.1 Driver: Rising Prevalence 72
7.1.1 Sports-Related Injuries 72
7.1.2 Aging 72
7.1.3 Trauma 73
7.2 Driver: Hip Arthroscopy 74
7.2.1 Femoroacetabular Impingement Growth 75
7.2.2 Hip Arthroscopy Fellowship Training Programs 76
7.3 Driver: Knee and Shoulder Arthroscopy 76
7.4 Driver: Revision Surgery 77
7.5 Driver: Patient Demand and Awareness 78
7.6 Driver: Orthobiologics Development 79
7.6.1 Bone Grafts 79

7.6.2 Platelet-Rich Plasma 80
7.7 Driver: Rising Competition and Innovation Through Small Players 80
7.8 Driver: Materials Development 81
7.8.1 Composite Materials and Biopolymers 81
7.8.2 Bioabsorbables 82
7.8.3 Metallic Alloys in Orthopedics 82
7.9 Barrier: Arthroscopy's Questionable Outcomes 83
7.9.1 Hip Arthroscopy 83
7.9.2 Knee Arthroscopy 84
7.10 Barrier: Steep Learning Curve 85
7.11 Barrier: Reimbursement 86
7.12 Barrier: Burden of Rising Regulation 87
7.13 Barrier: Proving Efficacy 88

7.14 Barrier: Medical Device Excise Tax 89
7.15 Substitute: Open Surgery Versus Minimally-Invasive Arthroscopy 90
7.16 Substitute: Conservative Treatment Options 90
8 Competitive Assessment 92
8.1 Overview 92
8.2 Marketed Products in Sports Medicine 92
8.2.1 Arthrex 92
8.2.2 ArthroCare Corporation 99
8.2.3 Biomet 103
8.2.4 ConMed Corporation 107
8.2.5 DePuy Mitek 112
8.2.6 Smith & Nephew 115
8.2.7 Stryker 118
8.2.8 Tornier 120
9 Pipeline Assessment 122
9.1 Overview 122
9.2 Product Profiles 122
9.2.1 Bioretec Drug-Releasing Screws 122
9.2.2 Nanova Bioabsorbable Bone Screws 122
9.2.3 MinInvasive Arthroscopic Suture Passer 122

9.2.4 SpineSmith Pipeline 123
9.2.5 DePuy Mitek FMS VUE 123
9.2.6 Pivot Medical Hip Arthroscopy System 123
9.2.7 University of Florida Shoulder Labral Anchor Delivery System 123
9.2.8 University of California at San Diego Cartilage Regeneration Device 123
10 Clinical Trials to Watch 124
10.1 Overview 124
10.2 Can Shoulder Arthroscopy Work (CSAW) Study 124
10.3 Arthroscopy in the Treatment of Degenerative Medial Meniscus Tear 124
10.4 Knee Arthroscopy Cohort Southern Denmark 125
10.5 Hip Arthroscopy Versus Conservative Management of Femoroacetabular Impingement 125
10.6 Femoroacetabular Impingement Randomized Controlled Trial 126
10.7 Multicenter ACL Revision Study (MARS) 126
10.8 Arthroscopic Versus Open Stabilization for Traumatic Shoulder Instability 127
10.9 Microfracture in the Knee Study 127
10.10 Single- Versus Double-Row Suture Anchor Repair in Medium to Large Rotator Cuff Tears 128
10.11 Early Surgery Versus Conservative Therapy for Meniscal Injuries in Older Patients (ESCAPE) 128
10.12 Arthroscopic Rotator Cuff Repair of Full Thickness Tears With and Without Arthroscopic Acromioplasty 129
10.13 Arthroscopic Rotator Cuff Repair With Platelet-Rich Plasma 130
10.14 Tibial Tunnel Widening in ACL Reconstruction-Comparing Two Bioscrews 130
11 Current and Future Players 131
11.1 Trends in Corporate Strategy 131
11.2 Company Profiles 132
11.2.1 Arthrex 132

11.2.2 ArthroCare Corporation 135
11.2.3 Biomet 137
11.2.4 ConMed Corporation 140
11.2.5 DePuy Companies 142
11.2.6 Smith & Nephew 144
11.2.7 Stryker 147
11.2.8 Tornier 149
11.2.9 Wright Medical Group 151
11.2.10 Other Key Players in Sports Medicine 154
12 Market Outlook 159
12.1 Company Market Share 159
12.1.1 Overview 159
12.1.2 EU Market Share 159
12.2 By Market Segment 162
12.2.1 Overview 162

12.2.2 Arthroscopy Implants 164
12.2.3 Arthroscopic Shavers 165
12.2.4 Arthroscopes 166
12.2.5 Arthroscopic Radio Frequency Wands 167
12.2.6 Arthroscopic Visualization Systems 168
12.2.7 Arthroscopic Fluid Management Systems 169
12.3 By Geography 170
12.3.1 EU Overview 170
13 Appendix 183
13.1 Bibliography 183
13.2 Abbreviations 192
13.3 Research Methodology 197
13.3.1 Overview 197
13.3.2 Coverage 197
13.3.3 Secondary Research 197
13.4 Physicians and Specialists Included in this Study 199
13.4.1 Dr. Henry D.E. Atkinson 199
13.4.2 Dr. Joshua Alpert 199
13.4.3 Dr. Andrea Ferretti 199

13.4.4 Dr. Alejandro Gonzalez Della Valle 199
13.4.5 Dr. Andreas Imhoff 199
13.4.6 Dr. Marcello Zaia Oliveira 199
13.4.7 Dr. Vidhya Ravi 200
13.4.8 Dr. Elvire Servien 200
13.4.9 Dr. Yotaro Yamakado 200
13.5 Primary Research 201
13.5.1 Primary Research - Key Opinion Leader Interviews 201
13.5.2 Primary Research - Physician and Industry Interviews 201
13.5.3 Expert Panel Validation 202
13.6 Forecasting Methodology 202
13.7 About the Authors 204
13.7.1 Analysts 204
13.7.2 Global Head of Healthcare 205
13.8 About MediPoint 206
13.9 About GlobalData 206
13.10 Disclaimer 206

1.1 List of Tables

Table 1: Most Common Soft Tissue Injuries to the Extremities in Sports Medicine 31
Table 2: EU Growth Rate for Arthroscopy by Joint and Country, 2013-2020 38
Table 3: Primary Differences Between FDA Approval and CE-Marking of Medical Devices 39
Table 4: Direct, Indirect, and Intangible Costs of Orthopedics 51
Table 5: Potential Market for Meniscus Treatment Types 55
Table 6: Metal Implant CharacteristicsThat Can Be Improved 83
Table 7: Arthrex Shoulder Implants 94
Table 8: Arthrex, Shoulder Instrumentation 95
Table 9: Arthrex, Knee Sutures and Suture Anchors 95
Table 10: Arthrex, Knee Graft Fixation Devices and Meniscal Products 96
Table 11: Arthrex, Hip Implants and Instruments 97
Table 12: Arthrex, Arthroscopy Procedure Capital Equipment 98
Table 13: Arthrex, Implants SWOT Analysis 98
Table 14: Arthrex, Instrumentation SWOT Analysis 99
Table 15: Arthrocare, Suture Implants 100
Table 16: ArthroCare, Suture Management Products 101
Table 17: ArthroCare, Cruciate Ligament Graft Fixation Products 102
Table 18: ArthroCare, Capital Equipment and Instruments 102
Table 19: ArthroCare, Implants SWOT Analysis 103

Table 20: Arthrocare, Instruments and Capital Equipment SWOT Analysis 103
Table 21: Biomet, Shoulder Arthroscopy Products 104
Table 22: Biomet, Knee Arthroscopy Products 105
Table 23: Biomet's Other Joints Arthroscopy Products 106
Table 24: Biomet, Capital Equipment Sports Medicine Products 106
Table 25: Biomet Implants SWOT Analysis 106
Table 26: Biomet, Capital Equipment SWOT Analysis 107
Table 27: ConMed, Shoulder Arthroscopy Products 108
Table 28: ConMed, Knee Arthroscopy Products 109
Table 29: ConMed, Small Joint and Hip Arthroscopy Products 110
Table 30: ConMed, Instruments and Capital Equipment 111
Table 31: ConMed, Implants SWOT Analysis 111
Table 32: ConMed, Capital Equipment SWOT Analysis 111
Table 33: DePuy Mitek, Fixation Devices 113
Table 34: DePuy, Mitek Instruments 114
Table 35: DePuy Mitek, Capital Equipment 114
Table 36: DePuy Mitek Implants, SWOT Analysis 115
Table 37: DePuy Mitek, Capital Equipment SWOT Analysis 115
Table 38: Smith & Nephew, Fixation Devices 116
Table 39: Smith & Nephew, Instruments and Capital Equipment 117

Table 40: Smith & Nephew Implants, SWOT Analysis 117
Table 41: Smith & Nephew, Capital Equipment SWOT Analysis 117
Table 42: Stryker, Fixation Devices 118
Table 43: Stryker, Instrumentation 119
Table 44: Stryker, Capital Equipment 119
Table 45: Stryker, Fixation Devices SWOT Analysis 120
Table 46: Stryker, Instrumentation and Capital Equipment SWOT Analysis 120
Table 47: Tornier Sports Medicine Products 121
Table 48: Tornier, Product Family SWOT Analysis 121
Table 49: Can Shoulder Arthroscopy Work (CSAW) 124
Table 50: Arthroscopy in the Treatment of Degenerative Medial Meniscus Tear 125
Table 51: Knee Arthroscopy Cohort Southern Denmark 125
Table 52: Hip Arthroscopy Versus Conservative Management of Femoroacetabular Impingement 126
Table 53: Femoroacetabular Impingement Randomized Controlled Trial 126
Table 54: Multicenter ACL Revision Study (MARS) 127
Table 55: Arthroscopic Versus Open Stabilization for Traumatic Shoulder Instability 127

Table 56: Results at 10 to 14 Years After Microfracture in the Knee 128
Table 57: Single Versus Double Row Suture Anchor Repair in Medium to Large Rotator Cuff Tears 128
Table 58: Early Surgery Versus Conservative Therapy for Meniscal Injuries in Older Patients (ESCAPE) 129
Table 59: Arthroscopic Rotator Cuff Repair of Full Thickness Tears With and Without Arthroscopic Acromioplasty 129
Table 60: Arthroscopic Rotator Cuff Repair With Platelet-Rich Plasma in Large to Massive Tears 130
Table 61: Tibial Tunnel Widening in Anterior Cruciate Ligament Reconstruction Comparing Two Bioscrews 130
Table 62: Company Profile - Arthrex 133
Table 63: SWOT Analysis - Arthrex 134
Table 64: Company Profile - ArthroCare Corporation 136
Table 65: SWOT Analysis - ArthroCare Corporation 137
Table 66: Company Profile - Biomet 138
Table 67: SWOT Analysis - Biomet 139
Table 68: Company Profile - ConMed Corporation 141
Table 69: SWOT Analysis - ConMed Corporation 142
Table 70: Company Profile - DePuy Companies 143
Table 71: SWOT Analysis - DePuy Companies 144
Table 72: Company Profile - Smith & Nephew 145
Table 73: SWOT Analysis - Smith & Nephew 146
Table 74: Company Profile - Stryker 148
Table 75: SWOT Analysis - Stryker 149

Table 76: Company Profile - Tornier 150
Table 77: SWOT Analysis - Tornier 151
Table 78: Company Profile - Wright Medical Group 152
Table 79: SWOT Analysis - Wright Medical Group 153
Table 80: Other Sports Medicine Companies in the US Market 154
Table 81: Other Sports Medicine Companies in the EU Market 155
Table 82: Other Sports Medicine Companies in the APAC Market 157
Table 83: EU Sports Medicine Sales Forecast ($m), 2011-2020 163
Table 84: EU Sports Medicine Sales Forecast ($m), Arthroscopy Implants, 2011-2020 164
Table 85: EU Sports Medicine Sales Forecast ($m), Arthroscopic Shavers, 2011-2020 165
Table 86: EU Sports Medicine Sales Forecast ($m), Arthroscopes, 2011-2020 166
Table 87: EU Sports Medicine Sales Forecast ($m), Arthroscopic RF Wands, 2011-2020 167
Table 88: EU Sports Medicine Sales Forecast ($m), Arthroscopic Visualization Systems, 2011-2020 168
Table 89: EU Sports Medicine Sales Forecast ($m), Arthroscopic Fluid Management Systems, 2011-2020 169
Table 90: EU Sports Medicine Implant and Capital Equipment Sales ($m) Forecast by Country, 2011-2020 170
Table 91: France Sports Medicine Sales Forecast ($m), 2011-2020 174
Table 92: Germany Sports Medicine Sales Forecast ($m), 2011-2020 177
Table 93: Italy Sports Medicine Sales Forecast ($m), 2011-2020 179
Table 94: Spain Sports Medicine Sales Forecast ($m), 2011-2020 180
Table 95: UK Sports Medicine Sales Forecast ($m), 2011-2020 182
Table 96: Primary Research Interviews Completed in Sports Medicine 202

1.2 List of Figures
Figure 1: Global Arthroscopic Procedure Volumes by Joint, 2011-2020 35
Figure 2: EU Arthroscopic Procedure Volumes, 2011-2020 36
Figure 3: EU Arthroscopic Procedure Volumes by Joint, 2011-2020 37

Figure 4: Sources of Orthopedic Trauma (%) (n=103) 74
Figure 5: France Market Share for Arthroscopy, 2012 160
Figure 6: Germany Market Share for Arthroscopy, 2012 160
Figure 7: Italy Market Share for Arthroscopy, 2012 161
Figure 8: Spain Market Share for Arthroscopy, 2012 161
Figure 9: UK Market Share for Arthroscopy, 2012 162
Figure 10: EU Sports Medicine Sales Forecast ($m), 2011-2020 163
Figure 11: EU Sports Medicine Sales Forecast ($m), Arthroscopy Implants, 2011-2020 164
Figure 12: EU Sports Medicine Sales Forecast ($m), Arthroscopic Shavers, 2011-2020 165
Figure 13: EU Sports Medicine Sales Forecast ($m), Arthroscopes, 2011-2020 166
Figure 14: EU Sports Medicine Sales Forecast ($m), Arthroscopic RF Wands, 2011-2020 167
Figure 15: EU Sports Medicine Sales Forecast ($m), Arthroscopic Visualization Systems, 2011-2020 168
Figure 16: EU Sports Medicine Sales Forecast ($m), Arthroscopic Fluid Management Systems, 2011-2020 169
Figure 17: Arthroscopy Implants Revenue by Major Market, 2013 and 2020 171
Figure 18: Arthroscopy Capital Equipment Revenue by Major Market, 2013 and 2020 172
Figure 19: France Sports Medicine Sales Forecast ($m), 2011-2020 175
Figure 20: Germany Sports Medicine Sales Forecast ($m), 2011-2020 177
Figure 21: Italy Sports Medicine Sales Forecast ($m), 2011-2020 179
Figure 22: Spain Sports Medicine Sales Forecast ($m), 2011-2020 181
Figure 23: UK Sports Medicine Sales Forecast ($m), 2011-2020 182

Companies Mentioned

Arthrex
ArthroCare Corporation
Biomet
ConMed Corporation
DePuy Companies
Smith & Nephew
Stryker
Tornier
Wright Medical Group

To order this report: MediPoint: Sports Medicine - EU Analysis and Market Forecasts
http://www.reportlinker.com/p02088223/MediPoint-Sports-Medicine---EU-Analysis-and-Market-Forecasts.html

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker